Taivex Therapeutics Corporation
Taivex Therapeutics Corporation
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Tolerability Study for T-1301 Capsules to Treat Advanced Solid Tumors | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 1 | 2026-10-05 | NCT05156203 | |
| Safety and Tolerability Study for T-1201 Injection 100 mg Kit in Patients With Advanced Solid Tumors | Advanced Solid Tumor | Recruiting | Phase 1 | 2026-10-02 | NCT04866641 |